Randomized Crossover Comparison of the Short-Term Efficacy and Safety of Single Half-Dose Silodosin and Tamsulosin Hydrochoride in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.

Randomized Crossover Comparison of the Short-Term Efficacy and Safety of Single Half-Dose Silodosin and Tamsulosin Hydrochoride in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.

Item

http://www.wikidata.org/entity/Q48880439

Q48880439

about

A randomized, comparative, open-label study of efficacy and tolerability of alfuzosin, tamsulosin and silodosin in benign prostatic hyperplasia Comparative Effectiveness of Newer Medications for Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis.Safety and efficacy of tamsulosin, alfuzosin or silodosin as monotherapy for LUTS in BPH - a double-blind randomized trial.Effect of α-receptor blockers on lower urinary tract symptoms, sexual function and quality of life in young and middle-aged men with benign prostatic hyperplasia.Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.Percent decrease of serum prostate-specific antigen after dutasteride administration is equivalent in men with clinical benign prostatic hyperplasia having baseline prostate-specific antigen >10 ng/mL and those having baseline prostate-specific anti

P2860

Q36780186-3184B411-B85B-48E2-88D3-077B23137F97 Q38975318-25DE89D3-1DF0-4F1D-B4A8-148CF22C5C61 Q41014190-22FFDBBB-BEF3-4FFF-90BD-F9DC1F4BF2F7 Q41018045-06A38F6F-A229-439B-9FF0-6D3E7397A68F Q47434739-FC00182E-C591-428E-8724-999EFFF284D1 Q54714433-7545557C-A9D8-4036-BD87-62AC93FCB9C1

P2860

Randomized Crossover Comparison of the Short-Term Efficacy and Safety of Single Half-Dose Silodosin and Tamsulosin Hydrochoride in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.

Item

http://www.wikidata.org/entity/Q48880439

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Randomized Crossover Compariso ...... Benign Prostatic Hyperplasia.

@en

Randomized Crossover Compariso ...... Benign Prostatic Hyperplasia.

@nl

type

Item

label

Randomized Crossover Compariso ...... Benign Prostatic Hyperplasia.

@en

Randomized Crossover Compariso ...... Benign Prostatic Hyperplasia.

@nl

prefLabel

Randomized Crossover Compariso ...... Benign Prostatic Hyperplasia.

@en

Randomized Crossover Compariso ...... Benign Prostatic Hyperplasia.

@nl

P1476

Randomized Crossover Compariso ...... Benign Prostatic Hyperplasia.

@en

P2093

Akira Noro

http://www.w3.org/2001/XMLSchema#string

Hideki Takeshita

http://www.w3.org/2001/XMLSchema#string

Kimitoshi Saito

http://www.w3.org/2001/XMLSchema#string

Koji Chiba

http://www.w3.org/2001/XMLSchema#string

Satoshi Washino

http://www.w3.org/2001/XMLSchema#string

Shingo Moriyama

http://www.w3.org/2001/XMLSchema#string

Susumu Horiuchi

http://www.w3.org/2001/XMLSchema#string

Yoshiaki Arai

http://www.w3.org/2001/XMLSchema#string

P2860

Subtype specific regulation of human vascular alpha(1)-adrenergic receptors by vessel bed and age.

Silodosin, a novel selective alpha 1A-adrenoceptor selective antagonist for the treatment of benign prostatic hyperplasia.

Quantification and distribution of alpha 1-adrenoceptor subtype mRNAs in human prostate: comparison of benign hypertrophied tissue and non-hypertrophied tissue.

Short-term effects of crossover treatment with silodosin and tamsulosin hydrochloride for lower urinary tract symptoms associated with benign prostatic hyperplasia.

Efficacy of silodosin for relieving benign prostatic obstruction: prospective pressure flow study.

Silodosin in the treatment of the signs and symptoms of benign prostatic hyperplasia: a 9-month, open-label extension study.

Adrenergic and cholinergic receptors in the human prostate, prostatic capsule and bladder neck.

Rapid efficacy of the highly selective alpha1A-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia: pooled results of 2 phase 3 studies.

Effect of silodosin on detrusor overactivity in the male spontaneously hypertensive rat.

Non-inferiority of silodosin 4 mg once daily to twice daily for storage symptoms score evaluated by the International Prostate Symptom Score in Japanese patients with benign prostatic hyperplasia: a multicenter, randomized, parallel-group study.

P304

38-43

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/LUTS.12106

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26789541

http://www.w3.org/2001/XMLSchema#string

Randomized Crossover Comparison of the Short-Term Efficacy and Safety of Single Half-Dose Silodosin and Tamsulosin Hydrochoride in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.

about

P2860

P2860

Randomized Crossover Comparison of the Short-Term Efficacy and Safety of Single Half-Dose Silodosin and Tamsulosin Hydrochoride in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698